Skip to main content
. 2010 May 25;4:71–79. doi: 10.2147/dddt.s3687

Table 1.

ACAM2000 efficacy studies in animal models

Animal species Vaccinations Vaccination dose Challenge virus and dose Challenge route Outcome Reference
BALB/C mice ACAM2000™
ACAM1000
Dryvax®
For all 104,105, 106 or 107 pfu/mL Vaccinia virus-WR strain 100 × LD50 IN All vaccines provided equivalent protection Monath et al6
Cynomolgus macaques ACAM2000™
Dryvax®
4.4 × 108 pfu/mL
1.5 × l08 pfu/mL
Monkeypox virus/Zaire79
3.8 × l07 pfu/mL
IV Dryvax® and ACAM2000™
Provided equivalent protection
Marriott et al22